Detalles de la búsqueda
1.
Significantly higher pathologic complete response (pCR) after the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: Evidence from a meta-analysis of randomized controlled trials.
J Cancer
; 9(17): 3168-3176, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30210640
2.
Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis.
Ther Clin Risk Manag
; 14: 1789-1797, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30310287
3.
Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis.
PLoS One
; 12(6): e0179680, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28640902
Resultados
1 -
3
de 3
1
Próxima >
>>